Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Michael E. Thase, MD: Editor's Letter
1
x
$
0.00
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
1
x
$
30.00
Amisulpride for Clozapine Induced Sialorrhea
1
x
$
30.00
The Important Role of Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphomas
1
x
$
0.00
Management of Aggressive Lymphoma
1
x
$
0.00
Metastasis-Suppressor Genes: A Review and Perspective on an Emerging Field
1
x
$
0.00
Analysis of Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
1
x
$
30.00
Shaina D. Barnes, Pharm D: Isolated Aripiprazole Drug Interaction with Estrogen
1
x
$
30.00
Complete Resolution of Catatonia Following a Single Intravenous Lorazepam Challenge Test: An Early Intervention in Psychosis Case Report
1
x
$
30.00
The Hamilton Rating Scale for Depression
1
x
$
0.00
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
1
x
$
0.00
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Alisa B. Busch - Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
1
x
$
30.00
Guía para la dosificación y el monitoreo de psicotrópicos para niños y adolescentes
1
x
$
30.00
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
Flavonoids Join the War on Cancer
1
x
$
0.00
Bereavement During a Course of TMS for MDD: A Case Report
1
x
$
30.00
Federica Tozzi, MD: Candidate Gene Studies in Eating Disorders
1
x
$
30.00
A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans
1
x
$
30.00
View Cart
Checkout
Home
Store
“A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
$
30.00
Add to cart
Details
John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment
$
30.00
Add to cart
Details
A Case of Clozapine Induced Mania-Like Symptoms in the Treatment of Schizophrenia
$
30.00
Add to cart
Details
A Bell’s Palsy Case Probably Related to Sertraline Use
$
30.00
Add to cart
Details
The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles
$
30.00
Add to cart
Details
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 46 No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
The Black Book of Psychotropic Dosing and Monitoring
$
30.00
Add to cart
Details
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
$
30.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
$
30.00
Add to cart
Details
A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans
$
30.00
Add to cart
Details
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains
$
30.00
Add to cart
Details
Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 37 Supplement No. 2 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine
$
30.00
Add to cart
Details
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
$
30.00
Add to cart
Details
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
$
30.00
Add to cart
Details
Previous
1
2
3
4
…
44
Next
Page load link
Go to Top
